Table 1.
Demographics and peri-operative characteristics of the study cohort (No. = 251).
| Age (Years) | |
|---|---|
| Median (IQR) | 14 (13–16) |
| Range | 9–21 |
| BMI (kg/m2) | |
| Median (IQR) | 20.1 (17.9–21.6) |
| Range | 14.4–26.1 |
| Varicocele clinical grade (No. (%)) | |
| III | 183 (73%) |
| II | 9 (4%) |
| Type of presentation (No. (%)) | |
| Primary | 235 (94%) |
| Recurrent after open surgery | 16 (6%) |
| Operative time (min) | |
| Median (IQR) | 35 (30–45) |
| Range | 12–80 |
| Presence of collateral veins (No. (%)) | 114 (45.4%) |
| Type of SA (No. (%)) | |
| Aethoxysclerol | 117 (46.6%) |
| Fibrovein | 134 (53.4%) |
| Amount of SA (mL) | |
| Median (IQR) | 3 (3–4) |
| Range | 1.5–8 |
| Fluoroscopy time (min) | |
| Median (IQR) | 38.5 (27.7–54) |
| Range | 16–149 |
| DAP (cGycm2) | |
| Median (IQR) | 89.6 (62.5–143.9) |
| Range | 22.9–432.9 |
| Effective Dose (mSv) | |
| Median (IQR) | 0.19 (0.14–0.31) |
| Range | 0.06–0.73 |
Keys: BMI = body mass index; SA= sclerosing agent; DAP = dose area product.